ArticleMicrobiology spectrum2026
Bacteriocin-mediated intraspecies competition driven by acquired Bac41 operon in epidemic
Jinglin Yue, Tingzhu Yao, Nan Chen, Hengkun Wei, Aoze Cheng, Chengbo Rong, Huizhu Wang, Hui Li, Jingyuan Liu, Mingxi Hua and 1 more
Abstract read
In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Jinglin Yue *Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-0299-7209 Tingzhu Yao *Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Nan Chen *Department of Blood Transfusion, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Hengkun WeiBiomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Aoze ChengBiomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Chengbo RongBiomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-3784-0591 Huizhu WangDepartment of Critical Care Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hui LiDepartment of Stomatology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Jingyuan Liu *Department of Critical Care Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-0592-9789 Mingxi Hua *Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-2525-6822 Chen Chen *Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-1765-8899 Funding
Beijing Clinical Key Specialty Construction Project Intensive Care Medicine Beijing Ditan HospitalBeijing Municipal Natural Science Foundation 7252073Beijing Natural Science Foundation 7242079High-level public health talents lingjunrencai-02-06High-level public health talents xuekedaitouren-03-13
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
BacteriocinsEnterococcus faecalisGram-Positive Bacterial InfectionsOperonAnti-Bacterial AgentsBacterial ProteinsChinaGenome, BacterialHumansAnti-Bacterial AgentsBacterial ProteinsBacteriocinsbacteriocinEnterococcus faecalisepidemic cloneintraspecies competition
Identifiers
PMID42560111
PMCPMC13532309
What Socratic holds
Textmetadata
Read underepoch 390